Treatment Options Targeting Brain’s Thermostat Lead to Innovations in Non-hormonal Drugs
High prevalence of fluctuating estrogen levels and depleting musculoskeletal health among women are some of the key drivers contributing to the robust growth of the menopausal hot flashes treatment market. Hence, healthcare companies are increasing their clinical trials in non-hormonal products to meet various cases. Recently, in January 2020, the U.K.-based clinical-stage biotech company KaNDy Therapeutics, announced positive data of their Phase 2b “SWITCH-1” clinical trial of their novel lead non-hormonal drug candidate, NT-814, for the treatment of menopause. Though the hormonal treatment type segment is expected to lead the menopausal hot flashes treatment market, non-hormonal treatment type segment is anticipated for exponential growth during the forecast period.
Get the sample copy of report@ https://qyresearchmedical.com/sample/111711
Companies in the market for menopausal hot flashes are increasing R&D in treatment options that target the brain’s thermostat to reduce incidence of hot flashes in women. Such innovations are creating value-grab opportunities for companies in the market menopausal hot flashes treatment market, whilst improving the quality of life of postmenopausal women.
Femtech to Explore Untapped Potential in Women’s Midlife Health Issues
The menopausal hot flashes treatment market is expected to grow at a CAGR of 6% during the forecast period. Most women from Generation X are now in their 40s and are technologically proficient. Likewise, online drug sales is anticipated to flourish in the market for menopausal hot flashes. However, there is a lack of interest from the femtech toward solving the issues of women’s midlife health issues.
The femtech sector has been more active toward solving the issues of menstrual health and pregnancy. However, there is a growing need for attention toward women’s midlife health issues such as menopausal hot flashes. Hence, companies are exploring untapped opportunities to address the stigma and associated silence pertaining to symptoms of menopause.
Companies in the menopausal hot flashes treatment market are targeting digitally literate women to create awareness about the issues related to menopause through social media. They are increasing their efficacy in complementary and alternative medicine (CAM) for management of hot flashes.
Innovations in Devices Attract Healthcare Companies
Apart from innovations in medicines, companies in the menopausal hot flashes treatment market are recommending women toward lifestyle modifications through online media channels. Likewise, companies are developing cutting-edge devices that suit the needs of women. For instance, the introduction of the Menopod™ has led to the growth of market for menopausal hot flashes, owing to its compact computer mouse-like shape and portability. The advent of smartwatch-like devices that act as a personal thermostat for women is also driving the global market.
Due to high prevalence of tech-savvy women in their late 40s, companies in the market for menopausal hot flashes are unearthing value opportunities with the development of mobile apps. These mobile apps are providing healthcare companies with important insights about the frequency of hot flashes in women. On the other hand, companies in the menopausal hot flashes treatment market are increasing research in customizable mattresses that offer cooling and heating temperature controls.
View full report@ https://qyresearchmedical.com/report/menopausal-hot-flashes-treatment-market-treatment-type-hormonal-treatment-estrogen-progesterone-and-estrogen-progesterone-combination-non-hormonal-treatment-antidepressant-gabapentin-pregabalin-and-clon-019-2030/111711
Cognitive Behavior Therapy Proves Effective in Addressing Complications Associated with Hot Flashes
The demand for nonpharmacologic treatment options is projected to escalate in the menopausal hot flashes treatment market. Thus, healthcare providers are adopting cognitive behavior therapy to improve menopause symptoms. This novel therapy is being highly publicized for not only treating hot flashes, but is also effective for other menopause symptoms. Companies in the menopausal hot flashes treatment market are creating awareness about cognitive behavior therapy, owing to its advantages of modifying dysfunctional emotions, behaviors and thoughts that enhance personal coping strategies. Since researchers have gained clinical success with the help of cognitive behavior therapy for the treatment of anxiety and depression, healthcare companies are expanding their healthcare services using the novel therapy.
Complications associated with menopausal hot flashes such as sleep disturbances and low-productivity levels in professional environments are increasing the demand for cognitive behavior therapy among patients. Long-term effectiveness of cognitive behavior therapy post treatment are creating lucrative opportunities for healthcare providers. Thus, healthcare companies are increasing efforts to conduct large-scale clinical trials in order to analyze its effectiveness in highly symptomatic women.
Apart from innovations in medicines, alternative options such as weight-training and lifestyle modifications are proving to be effective for hot flashes. The hormone replacement therapy is highly popular in the menopausal hot flashes treatment market. However, controversies encircling the risk of blood clots, stroke, and some cancers pose a barrier for market growth. Hence, companies should tap opportunities in alternative treatment options such as cognitive behavior therapy, which is not only effective in the management of hot flashes, but also treats other symptoms such as anxiety and sleep disorders. Digitalization of health is another key driver contributing toward market growth, as femtech can target tech-savvy women through social media and innovative mobile apps.
Menopausal Hot Flashes Treatment Market: Overview
Menopause is defined as the permanent cessation of menses that may occur in as early as the thirties or as late as the sixties. The treatment and management of menopausal women has been a matter of great apprehension in the last few decades, both in terms of epidemiology and medical scientific research.
The most common menopausal symptoms, including vasomotor symptoms (menopausal hot flashes), insomnia, vaginal atrophy, altered cognitive function, dementia, depression, and loss of muscle mass, can affect up to 80% of women during menopause and may be severe in up to 20% of these women
Menopausal hot flashes symptoms treatment drugs are used to reduce hot flashes, which is a form of temperature dysfunction that occurs due to changes in gonadal hormones. Menopausal hot flashes symptom treatments are classified into hormonal treatment, non-hormonal treatment, and alternative treatment (including herbal products).
Hormonal treatment products are available in different dosage forms such as pill, patch, and gel. The use of hormone replacement therapy (HRT) alleviates menopausal hot flashes symptoms and leads to a major improvement in quality of life for women with menopausal hot flashes symptoms.
Growing population of elderly women worldwide coupled with rise in menopausal hot flashes symptoms is a major factor responsible for the growth of global menopausal hot flashes treatment market
Increase in awareness about women’s health due to different public as well as private organizations initiatives is also fueling the growth of global menopausal hot flashes treatment market
Moreover, development of advanced products with alternative mode of administration and changes in lifestyle associated with early menopause are some of the major factors attributed for the growth of global menopausal hot flashes treatment market
Market Segmentation: Menopausal Hot Flashes Treatment Market
Based on treatment type, the global menopausal hot flashes treatment market has been divided into hormonal treatment, non-hormonal treatment, and alternative treatment
Hormonal treatment is further classified into estrogen, progesterone, and estrogen – progesterone combination
The non-hormonal segment is sub-segmented into antidepressant, gabapentin, pregabalin, and clonidine. Antidepressant is further divided into Paroxetine, Fluoxetine, Vanlafaxine, Desvanlafaxine, and others.
Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111711/2900
The alternative segment is further sub-divided into black cohosh, vitamin E, herbal medicines, and others
Based on distribution channel, the global menopausal hot flashes treatment market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies
Each of the segments has been analyzed in detail for global menopausal hot flashes treatment market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights
The global menopausal hot flashes report provides current and future revenues (US$ Mn) for each these segments for the period from 2017 to 2027, considering 2018 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2019 to 2027 along with menopausal hot flashes market size estimations.
Regional Overview: Menopausal Hot Flashes Treatment Market
In terms of region, the global menopausal hot flashes treatment market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been further divided into major countries and sub-regions.
The current and future market sizes for menopausal hot flashes treatment market in terms of revenue (US$ Mn) of these regional markets and their major countries have been provided in the report for the period from 2017 to 2027, with their CAGRs for the period from 2019 to 2027
The study also offers a list of recommendations, highlights, and useful insights of the global menopausal hot flashes treatment market which will help new companies willing to enter the market and existing companies to increase market shares, and help in the decision-making process
The global menopausal hot flashes report concludes with the company profiles section that includes key information about the major players in the market
Key players analyzed in this global menopausal hot flashes treatment market include –
- Pfizer Inc.
- Novartis AG
- Novo Nordisk A/S
- Allergan plc
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Hisamitsu Pharmaceutical Co., Inc.
- Merck & Co., Inc.
- GlaxoSmithKline plc
- TherapeuticsMD, Inc
Each of these players has been profiled in the menopausal hot flashes treatment market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments
Key Questions Answered in Menopausal Hot Flashes Treatment Market Report
- What is the sales/revenue generated by each treatment type segment of the menopausal hot flashes treatment market across all regions during the forecast period?
- What are the opportunities in the global menopausal hot flashes treatment market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which region is likely to expand at the fastest CAGR during the forecast period?
- Which menopausal hot flashes treatment type and distribution channel segments are expected to generate the highest revenue globally in 2027? Which segment is projected to expand at the highest CAGR during the forecast period?
- What is the market share or position of different companies operating in the global market in 2018?
Menopausal Hot Flashes Treatment Market – Segmentation
- Hormonal Treatment
- Estrogen-Progesterone Combination
- Non-hormonal Treatment
- Alternative Treatment
- Black Cohosh
- Vitamin E
- Herbal Medicines
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
TABLE OF CONTENT
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Menopausal Hot Flashes Treatment Market
4. Market Overview
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.3. Market Dynamics
4.4. Global Menopausal Hot Flashes Treatment Market Analysis and Forecasts, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Mergers, Acquisitions and Strategic Partnerships
5.3. Value Chain Analysis
6. Global Menopausal Hot Flashes Treatment Market Analysis and Forecasts, By Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product Type, 2017–2027
6.3.1. Hormonal Treatment
126.96.36.199. Estrogen-Progesterone Combination
6.3.2. Non-Hormonal Treatment
6.3.3. Alternative Treatment
188.8.131.52. Black Cohosh
184.108.40.206. Vitamin E
220.127.116.11. Herbal Medicines
6.4. Market Attractiveness By Product Type, 2019-2027
7. Global Menopausal Hot Flashes Treatment Market Analysis and Forecasts, By Distribution Channel
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Distribution Channel, 2017–2027
7.3.1. Hospital Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Online Pharmacies
7.4. Market Attractiveness By Distribution Channel, 2019-2027
8. Global Menopausal Hot Flashes Treatment Market Analysis and Forecasts, By Region
8.1. Key Findings
8.2. Market Value Forecast By Region
8.2.1. North America
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness By Country/Region, 2019-2027
9. North America Menopausal Hot Flashes Treatment Market Analysis and Forecast
9.1.1. Key Findings
9.2. Market Value Forecast By Product Type, 2017–2027
9.2.1. Hormonal Treatment
18.104.22.168. Estrogen-Progesterone Combination
9.2.2. Non-Hormonal Treatment
9.2.3. Alternative Treatment
22.214.171.124. Black Cohosh
126.96.36.199. Vitamin E
188.8.131.52. Herbal Medicines
9.3. Market Value Forecast By Distribution Channel, 2017–2027
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Online Pharmacies
9.4. Market Value Forecast By Country, 2017–2027
9.5. Market Attractiveness Analysis, 2019-2027
9.5.1. By Product Type
9.5.2. By Distribution Channel
9.5.3. By Country
10. Europe Menopausal Hot Flashes Treatment Market Analysis and Forecast
10.1.1. Key Findings
10.2. Market Value Forecast By Product Type, 2017–2027
10.2.1. Hormonal Treatment
10.2.1.3. Estrogen-Progesterone Combination
10.2.2. Non-Hormonal Treatment
10.2.3. Alternative Treatment
10.2.3.1. Black Cohosh
10.2.3.2. Vitamin E
10.2.3.3. Herbal Medicines
10.3. Market Value Forecast By Distribution Channel, 2017–2027
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Online Pharmacies
10.4. Market Value Forecast By Country, 2017–2027
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis, 2019-2027
10.5.1. By Product Type
10.5.2. By Distribution Channel
10.5.3. By Country
11. Asia Pacific Menopausal Hot Flashes Treatment Market Analysis and Forecast
11.1.1. Key Findings
11.2. Market Value Forecast By Product Type, 2017–2027
11.2.1. Hormonal Treatment
184.108.40.206. Estrogen-Progesterone Combination
11.2.2. Non-Hormonal Treatment
11.2.3. Alternative Treatment
220.127.116.11. Black Cohosh
18.104.22.168. Vitamin E
22.214.171.124. Herbal Medicines
11.3. Market Value Forecast By Distribution Channel, 2017–2027
11.3.1. Hospital Pharmacies
11.3.2. Retail Pharmacies
11.3.3. Online Pharmacies
11.4. Market Value Forecast By Country, 2017–2027
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis, 2019-2027
11.5.1. By Product Type
11.5.2. By Distribution Channel
11.5.3. By Country
12. Latin America Menopausal Hot Flashes Treatment Market Analysis and Forecast
12.1.1. Key Findings
12.2. Market Value Forecast By Product Type, 2017–2027
12.2.1. Hormonal Treatment
126.96.36.199. Estrogen-Progesterone Combination
12.2.2. Non-Hormonal Treatment
12.2.3. Alternative Treatment
188.8.131.52. Black Cohosh
184.108.40.206. Vitamin E
220.127.116.11. Herbal Medicines
12.3. Market Value Forecast By Distribution Channel, 2017–2027
12.3.1. Hospital Pharmacies
12.3.2. Retail Pharmacies
12.3.3. Online Pharmacies
12.4. Market Value Forecast by Country, 2017–2027
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis, 2019-2027
12.5.1. By Product Type
12.5.2. By Distribution Channel
12.5.3. By Country
13. Middle East & Africa Menopausal Hot Flashes Treatment Market Analysis and Forecast
13.1.1. Key Findings
13.2. Market Value Forecast By Product Type, 2017–2027
13.2.1. Hormonal Treatment
18.104.22.168. Estrogen-Progesterone Combination
13.2.2. Non-Hormonal Treatment
13.2.3. Alternative Treatment
22.214.171.124. Black Cohosh
126.96.36.199. Vitamin E
188.8.131.52. Herbal Medicines
13.3. Market Value Forecast By Distribution Channel, 2017–2027
13.3.1. Hospital Pharmacies
13.3.2. Retail Pharmacies
13.3.3. Online Pharmacies
13.4. Market Value Forecast By Country, 2017–2027
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis, 2019-2027
13.5.1. By Product Type
13.5.2. By Distribution Channel
13.5.3. By Country
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Market Share/Position Analysis By Company (2018)
14.3. Company Profiles
14.3.1. Pfizer Inc.
184.108.40.206. Company Overview (HQ, Business Segments, Employee Strength)
220.127.116.11. Company Financials
18.104.22.168. Growth Strategies
22.214.171.124. SWOT Analysis
14.3.2. Novartis AG
126.96.36.199. Company Overview (HQ, Business Segments, Employee Strength)
188.8.131.52. Company Financials
184.108.40.206. Growth Strategies
220.127.116.11. SWOT Analysis
14.3.3. Novo Nordisk A/S
18.104.22.168. Company Overview (HQ, Business Segments, Employee Strength)
22.214.171.124. Company Financials
126.96.36.199. Growth Strategies
188.8.131.52. SWOT Analysis
14.3.4. Allergan plc.
184.108.40.206. Company Overview (HQ, Business Segments, Employee Strength)
220.127.116.11. Company Financials
18.104.22.168. Growth Strategies
22.214.171.124. SWOT Analysis
14.3.5. Teva Pharmaceutical Industries Ltd.
126.96.36.199. Company Overview (HQ, Business Segments, Employee Strength)
188.8.131.52. Company Financials
184.108.40.206. Growth Strategies
220.127.116.11. SWOT Analysis
14.3.6. Mylan N.V.
18.104.22.168. Company Overview (HQ, Business Segments, Employee Strength)
22.214.171.124. Company Financials
126.96.36.199. Growth Strategies
188.8.131.52. SWOT Analysis
14.3.7. Hisamitsu Pharmaceutical Co., Inc.
184.108.40.206. Company Overview (HQ, Business Segments, Employee Strength)
220.127.116.11. Company Financials
18.104.22.168. Growth Strategies
22.214.171.124. SWOT Analysis
14.3.8. Merck & Co., Inc.
126.96.36.199. Company Overview (HQ, Business Segments, Employee Strength)
188.8.131.52. Company Financials
184.108.40.206. Growth Strategies
220.127.116.11. SWOT Analysis
14.3.9. GlaxoSmithKline plc.
18.104.22.168. Company Overview (HQ, Business Segments, Employee Strength)
22.214.171.124. Company Financials
126.96.36.199. Growth Strategies
188.8.131.52. SWOT Analysis
14.3.10. TherapeuticsMD, Inc.
184.108.40.206. Company Overview (HQ, Business Segments, Employee Strength)
220.127.116.11. Company Financials
18.104.22.168. Growth Strategies
22.214.171.124. SWOT Analysis
Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111711/2900
You can place an order or ask any questions, please feel free to contact firstname.lastname@example.org | +1 9197 992 333
QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.
For Latest Update Follow Us: